Your browser doesn't support javascript.
loading
Performance of plasma Aß42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status.
Bun, Shogyoku; Ito, Daisuke; Tezuka, Toshiki; Kubota, Masahito; Ueda, Ryo; Takahata, Keisuke; Moriguchi, Sho; Kurose, Shin; Momota, Yuki; Suzuki, Natsumi; Morimoto, Ayaka; Hoshino, Yuka; Seki, Morinobu; Mimura, Yu; Shikimoto, Ryo; Yamamoto, Yasuharu; Hoshino, Takayuki; Sato, Yoshiaki; Tabuchi, Hajime; Mimura, Masaru.
Afiliação
  • Bun S; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan. shogybun@keio.jp.
  • Ito D; Memory Center, Keio University School of Medicine, Tokyo, Japan.
  • Tezuka T; Department of Physiology, Keio University School of Medicine, Tokyo, Japan.
  • Kubota M; Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
  • Ueda R; Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
  • Takahata K; Office of Radiation Technology, Keio University Hospital, Tokyo, Japan.
  • Moriguchi S; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
  • Kurose S; Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
  • Momota Y; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
  • Suzuki N; Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
  • Morimoto A; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
  • Hoshino Y; Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
  • Seki M; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
  • Mimura Y; Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
  • Shikimoto R; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
  • Yamamoto Y; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
  • Hoshino T; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
  • Sato Y; Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
  • Tabuchi H; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
  • Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Alzheimers Res Ther ; 15(1): 149, 2023 09 04.
Article em En | MEDLINE | ID: mdl-37667408
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article